Evaluation of a New Chemotherapeutic Agent in Patients with "Advanced Refractory" Acute Leukemia. Studies of 6-Azauracil

Author:

FREIREICH EMIL J.1,FREI EMIL1,HOLLAND JAMES F.2,PINKEL DONALD2,SELAWRY OLEG2,ROTHBERG HARVEY3,HAURANI FARID4,TAYLOR ROBERT1,GEHAN EDMUND A.1

Affiliation:

1. National Cancer institute, Bethesda. Md.

2. Roswell Park Memorial Institute, Buffalo. N. Y.

3. Walter Reed Army Hosptial, Washington, D. C.

4. Jefferson Medical College, Philadelphia, Pa.

Abstract

Abstract 6-Azauracil was studied in patients with "advanced" acute leukemia, refractory to standard chemotherapy. Under the conditions of the study this compound was found to have no significant antileukemic activity. As a result, these data have defined the natural history of this phase of acute leukemia. A significant proportion (30 per cent) of these patients showed objective hematologic improvement even in the absence of effective specific therapy, which might be ascribed to a prospective new agent. The median survival from the onset of the study of this group of patients was two months, and survival patterns for adults and children were similar.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. History of Acute Leukemia;Neoplastic Diseases of the Blood;2017-09-09

2. Experimental and computational thermochemical studies of 6-azauracil derivatives;The Journal of Chemical Thermodynamics;2016-05

3. Introduction to Clinical Trials;Fundamentals of Clinical Trials;2015

4. Incorporating Tyrosine Kinase Inhibitors into Treatment Regimens for AML and ALL: Is There a Right or Wrong Way?;Current Hematologic Malignancy Reports;2014-03-16

5. History of Acute Leukemia;Neoplastic Diseases of the Blood;2012-07-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3